Related Experiment Videos
[Experience using cefpirome in patients with infections of the bronchopulmonary system]
Abstract:
The clinical efficacy and tolerance of cefpirome were estimated in the treatment of patients with bacterial infection of the respiratory tract. The estimate included 15 patients with acute and chronic bronchopulmonary diseases: 6 patients with acute pneumonia, 5 with exacerbated chronic purulent obstructive bronchitis and 4 with primary immune deficiency (agammaglobulinemia and acute pneumonia). Excellent and good total efficacy of the drug was stated in 6 and 8 patients respectively. In 1 patient the treatment was discontinued because of acute urticaria. Therefore, cefpirome is to be recommended as a highly efficient agent for the treatment of bronchopulmonary infection.
Insights
Cefpirome demonstrated high efficacy in treating respiratory tract infections, with excellent or good results in 14 out of 15 patients. One patient experienced urticaria, but the antibiotic is recommended for bronchopulmonary infections.
Area of Science:
- Infectious Diseases
- Pulmonology
- Pharmacology
Background:
- Bacterial respiratory tract infections pose a significant clinical challenge.
- Effective antibiotic therapy is crucial for managing bronchopulmonary diseases.
- Cefpirome is a cephalosporin antibiotic with broad-spectrum activity.